What a Comprehensive Health Assessment Should Actually Include

"Comprehensive" is not a regulated word. Any practice can use it, and the range of things it describes is enormous. Two programs at similar prices can differ by an order of magnitude in what they measure, whether they image anything at all, and — the part that matters most and gets discussed least — what happens to the results after you walk out.

This is a checklist for reading the fine print. It is a reporting summary of what the screening literature and current guidance discuss, written so you can bring specific questions to a physician who knows your history. It is not a recommendation for any individual, and nothing here should be the basis for a decision made alone.

Start with the question you are answering

Before comparing anything, get clear on which of two very different questions you want answered.

Am I sick? is a screening question. Standard primary care is built for it, usually covered by insurance, and generally does it well.

Where do I actually stand, and what is changing? is a characterisation question. It needs more resolution, it is mostly not covered, and it is the question most people are really asking when they start looking at these programs.

Both are legitimate. They call for different things, and a program that is good at one is not automatically good at the other.

The snapshot problem

This is the part that reframes everything else, and almost nobody explains it before you are already in the room.

A lipid panel describes right now. It reports what is circulating this month, under the conditions you have been living in lately. Change your diet, retest in ninety days, and the number will very likely improve. That improvement is real and it matters.

What it does not tell you is what the previous twenty years did.

Plaque accumulates. It is the running total of every year of exposure, not a reading of the current one. A man who ate badly through his thirties and straightened everything out at forty-five has genuinely changed what happens from here — and is still carrying whatever built up before that. His blood work can come back clean. His arteries are a separate question, with a separate answer, and the good number does not contain it.

A good number today is a statement about the road ahead. It is not an all-clear on the road behind.

Think of it the way you would think about a car. Checking the oil right after an oil change tells you the oil is clean. It tells you nothing about the wear on the engine, and no amount of fresh oil undoes a decade of running it hard. The dipstick was never measuring that.

This is why imaging is not simply a more expensive blood test. Blood markers describe the conditions under which plaque tends to form. A CIMT scan or a calcium score looks at whether it actually formed. Those are two different questions, and only one of them is about something that has already happened.

It is also why the age at which you start measuring matters more than most people expect. Not because anything is wrong yet, but because the first scan is the only one that can ever be your baseline. Every scan after it is only as useful as the one you have to compare it against.

Cardiovascular: past damage, not just current numbers

This is the category where the gap between standard and comprehensive is widest.

Look for lipids reported as particle counts, not only as cholesterol concentrations — ApoB in particular, which counts atherogenic particles directly. Look for Lp(a), measured at least once in your life; it is largely genetic, so a single measurement mostly settles the question, and most adults have never had it.

One thing worth understanding about Lp(a) in particular: it is largely set by your genes, and diet and training barely move it. That cuts against the intuition most people carry, which is that doing the right things should fix the numbers. A person who has done everything right can still be carrying an elevated Lp(a) and have no idea, because nothing in a standard panel would ever surface it and nothing in their lifestyle would have changed it. It needs measuring once, and then you know.

Then look for imaging, because this is where measurement stops being an estimate. A CIMT ultrasound measures carotid arterial wall thickness in about twenty minutes with no radiation. A coronary calcium score is a low-dose CT that quantifies calcified plaque in the coronary arteries. Blood markers describe the conditions under which plaque forms. Imaging looks at the artery.

A program that measures a dozen lipid fractions and images nothing has given you a more detailed version of an estimate.

Metabolic: the compensation, not just the output

The single most informative addition here is fasting insulin measured alongside fasting glucose.

Insulin resistance develops over years, and during those years the pancreas compensates by producing more insulin to hold glucose in range.

The plainest way to see it: glucose is the thermostat reading, and insulin is how hard the furnace is working to hold it there. A house at sixty-eight degrees with the furnace idling and a house at sixty-eight degrees with the furnace running flat out give you the same number on the wall. They are not in the same condition, and only one of them is about to have a problem. Measuring glucose alone is reading the wall. Measuring glucose alone watches the output of a system while ignoring how hard it is working. Fasting insulin — or an index calculated from both — sees the compensation while it is still happening.

Alongside that: HbA1c for the three-month average, the triglyceride-to-HDL ratio, and liver enzymes with some assessment of liver fat where relevant.

Body composition: four numbers the scale hides

Weight is one number standing in for at least four that behave differently.

A DEXA scan separates lean mass, fat mass, bone density and — importantly — visceral adipose tissue, the fat around the organs. Visceral fat tracks with metabolic risk in a way that total body weight and BMI do not, and two people at identical weights can differ substantially in how much of it they carry.

Bone density is the quietly valuable output here. It is rarely measured in men at all until something breaks, and it establishes a baseline that only becomes useful if you have it early.

Ask whether body composition is measured by DEXA or by bioimpedance. Both have a place; they are not equivalent in precision, and a program should tell you which it uses without being pressed.

Inflammatory and nutrient status

High-sensitivity CRP is the standard general inflammation marker. It is non-specific, which is a genuine limitation — it rises for many reasons — but persistent elevation without an obvious cause is worth pursuing.

Add homocysteine, vitamin D, B12, ferritin, and a thyroid panel that goes beyond TSH alone. Individually these are unremarkable. Collectively they are frequently the explanation for how somebody has been feeling.

What happens once the tests are done

This is the section to weight most heavily, and it is the one almost nobody compares.

It is also where the value of the whole exercise is decided. A single day of measurement produces a set of numbers. What turns those numbers into anything is somebody looking at them again next quarter, and the quarter after that, against what they were the first time. The first assessment is not really the product. The baseline it creates is, and a baseline nobody ever compares anything to is an expensive PDF.

That is worth keeping in mind when you compare a one-time assessment against something ongoing. The one-time version answers where you stand today. The ongoing version answers which direction you are moving, which is the question you actually wanted answered — and it only becomes answerable after the second and third measurements exist.

Is there a named physician who reviews every result with you, and how long is that conversation? A large panel delivered as a PDF and a portal login is data, not insight. The interpretation is most of the value, and the pattern across markers carries information that no single marker does.

Do you keep the results in a form you can compare? You want an export you own, in a format that lets you line up this year against next year. A portal you cannot get data out of is a subscription, not a record.

Is there a stated interval for re-measurement? The second and third data points are what turn a snapshot into a trend, and they only work if they are collected the same way.

What would a given finding change? Ask this one directly. A measurement worth taking is one where an abnormal result leads to a specific, named next step. If nobody can tell you what a result would change, it is not instrumentation — it is a number with a decimal point.

The honest limits

More measurement is not automatically better, and any assessment of these programs that skips this is incomplete.

Every additional marker carries some probability of an incidental finding — something mildly out of range that leads to a follow-up scan, a specialist visit, and occasionally a procedure, none of which needed to happen. The cost is real, it is sometimes physical, and it falls hardest on people who were healthy at the outset.

This is the substance of the guidelines that recommend against universal testing for various markers. Those guidelines are usually right about populations. They are making a statement about what happens when a test is run on a hundred million people, which is a different statement from whether a specific number would be informative for you, given your history and what you would do about it.

The reasonable position sits between "measure nothing beyond the standard panel" and "measure everything available." Measure what you would act on. Establish a baseline early enough that the trend has time to become readable. And be genuinely willing to hear that a finding does not require action, because a program that finds something requiring action every single time is telling you something about its business model rather than about you.